Plant Comparison
Perforate St John’s-wort vs White clover
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
First plant
Second plant
Show:
At a glance
Perforate St John’s-wort and White clover: they share 7 indicated uses (arthritis / joint pain, bruising, cold & flu, …); 3 pharmacological actions in common.
Perforate St John’s-wortWhite clover
Constituents33
Pharmacological actions611
Indicated uses915
Safety notes22
Cited sources3133
Indicated uses
Only Perforate St John’s-wort
EczemaInsomnia / sleeplessness
Shared (7)
Arthritis / joint painBruisingCold & fluInfection (general)Inflammation (general)Skin irritationWounds
Only White clover
Cancer (anticancer research)Immune supportMenstrual crampsMuscle spasmKidney supportLiver supportBlood sugar / diabetes supportCognitive function
Pharmacological actions
Only Perforate St John’s-wort
AntiviralEmollient / skin-soothingSedative / sleep support
Shared (3)
Anti-inflammatoryAntioxidantVulnerary (wound healing)
Only White clover
AntispasmodicImmunomodulator / immune supportNephroprotective (kidney support)Anticancer (preclinical)Hepatoprotective (liver support)AntimicrobialAntidiabetic (blood-sugar lowering)Neuroprotective / cognition support
Evidence face-off — shared uses
| Condition | Perforate St John’s-wort | White clover | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Bruising | 1/10 | 1/10 | Comparable evidence |
| Cold & flu | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 7/10 | Stronger for White clover |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Naphthodianthrones (hypericin, pseudohypericin)[4]
Red pigments historically used to standardise extracts; contribute to antiviral activity and are the compounds responsible for photosensitivity risk.
Phloroglucinols (hyperforin)[4]
Considered the principal compound behind the antidepressant activity and the main driver of the herb's potent CYP3A4/P-glycoprotein induction and drug-interaction profile.
Hyperforin
Flavonoids (hyperoside, quercetin, rutin)[4]
Antioxidant flavonoids contributing to overall activity.
FlavonoidsQuercetinRutin
Cyanogenic glycosides (trace)[30]
Present in small amounts; not significant in normal food or tea use.
Glycosides
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
Evidence: 1
Label: Arthritis / joint pain
inferred from antiviral action
Evidence: 1
Label: Infection (general)
inferred from anti-inflammatory action
Evidence: 1
Label: Inflammation (general)
inferred from sedative action
Evidence: 1
Label: Insomnia / sleeplessness
inferred from anti-inflammatory action
Evidence: 1
Label: Skin irritation
inferred from anti-inflammatory action
Evidence: 1
Label: Arthritis / joint pain
inferred from anticancer action
Evidence: 2
Label: Cancer (anticancer research)
inferred from immunomodulator action
Evidence: 1
Label: Cold & flu
inferred from anti-inflammatory action
Evidence: 2
Label: Inflammation (general)
inferred from antispasmodic action
Evidence: 1
Label: Menstrual cramps
inferred from antispasmodic action
Evidence: 1
Label: Muscle spasm
inferred from anti-inflammatory action
Evidence: 1
Label: Skin irritation
Evidence: 2
Label: Blood sugar / diabetes support
inferred from antimicrobial action
Evidence: 2
Label: Infection (general)
Safety, Cautions & Contraindications
Significant drug interactions: strongly induces CYP3A4 and P-glycoprotein, reducing plasma levels of many drugs including oral contraceptives, antiretrovirals, cyclosporine, warfarin, and digoxin. May cause photosensitivity (fair-skinned individuals). Do not combine with SSRIs, SNRIs, or MAOIs (serotonin syndrome risk). Avoid in bipolar disorder.
Duke (2002) rates St. John's wort as ++ (raised from earlier editions) and notes antidepressant, antiviral, antibacterial, and wound-healing activities at experimental and clinical levels. Hypericin and hyperforin are identified as key active constituents. Clinical evidence (score 2) confirms antidepressant efficacy in mild-to-moderate depression, and WHO/Commission E provide approval for this indication. Dose: 300 mg standardized extract (0.3% hypericin, 3–5% hyperforin) three times daily. Duke emphasizes the critical drug interaction: St. John's wort is a potent CYP3A4 inducer and can significantly reduce blood levels of many medications including oral contraceptives, cyclosporine, antiretrovirals, and warfarin. Avoid combined use with SSRIs (serotonin syndrome risk) and pharmaceutical antidepressants (Duke, 2002).
Generally very safe as a food and in moderate herbal use. Cyanogenic glucosides present in very small amounts — not significant in normal food or tea use. Isoflavones are phytoestrogens (as in red clover) — same precautions apply in hormone-sensitive conditions. Well tolerated by most people.
External Ids
Gbif: 3189486
Powo: urn:lsid:ipni.org:names:433719-1
Wikidata: Q158289
Gbif: 5358748
Wikidata: Q148675
Botanical Description
Erect, branching perennial herb with paired, oval leaves dotted with tiny translucent oil glands that look like pinpricks when held to the light (giving the species name 'perforatum'). Bright yellow, five-petalled flowers with numerous stamens and black dots along the petal edges are borne in flat-topped clusters, and release a reddish pigment when crushed.[4]
Height: 30-90 cm
Habit: Erect, branching perennial herb
Leaves: Paired, oval, dotted with tiny translucent oil glands
Flowers: Bright yellow, five-petalled, with numerous stamens and black-dotted petal edges, in flat-topped clusters
Stem: Erect, branching, with two raised longitudinal ridges
Root: Woody rootstock with spreading rhizomes
Fruit: Small, three-valved capsule
Flowering Period: June-September (traditionally around St John's Day, 24 June)
Low, creeping perennial herb rooting at the nodes, with trifoliate leaves, each leaflet oval and often marked with a pale chevron. Rounded white (sometimes pink-tinged) flower heads are borne on long stalks above the foliage.[30]
Height: 5-15 cm (creeping, flower stalks slightly taller)
Habit: Low, creeping, mat-forming perennial herb
Leaves: Trifoliate, each leaflet oval, often marked with a pale chevron
Flowers: Rounded white (sometimes pink-tinged) heads of small pea-like flowers on long stalks
Stem: Creeping, rooting at the nodes
Root: Fibrous roots with nitrogen-fixing nodules
Fruit: Small pod containing 3-4 seeds
Flowering Period: May-October
Habitat
Grows in grassland, roadsides, woodland clearings and waste ground on well-drained soils; native to Europe, Western Asia and North Africa and widely naturalised elsewhere, including North America and Australia.[4]
Grows in lawns, pastures, meadows and grassy waste ground; native to Europe and western Asia and now naturalised worldwide, including as a common lawn and forage plant.[30]
Harvesting
The flowering tops (flower and upper leaf) are cut in summer as the flowers open, around the traditional St John's Day period, and dried quickly in a warm, shaded, airy place to preserve the hypericin and hyperforin content.[4]
Parts: Flower, Leaf
Season: Summer, at flowering
Flowering heads and leaves are picked through the flowering season and dried in a warm, shaded, airy place.[30]
Parts: Flower, Leaf
Season: May-October
Traditional Uses
St John's wort has a centuries-long European folk reputation as a wound-healing and nerve tonic herb, traditionally used for mild wounds, burns and nerve pain and to lift low mood; this traditional mood-supporting use is now one of the most extensively clinically studied applications of any herbal medicine, with standardised extracts shown comparable to conventional antidepressants for mild-to-moderate depression.[1, 4]
White clover has a folk tradition, similar to but lighter than its relative red clover, as an anti-inflammatory and wound-healing remedy and mild expectorant, and modern research on its isoflavones and phenolics has additionally investigated antioxidant, kidney-protective and liver-protective activity.[30, 31, 32]
Preparations
Dosage
Standardised extract[1]
Clinical trials for mild-to-moderate depression commonly use around 300 mg of standardised extract three times daily (900 mg/day total); given extensive drug interactions, use should be discussed with a healthcare provider, especially alongside other medicines. Educational reference only, not a prescription.
Not documented
Drug Class Interactions
Drug Class: antidepressants-serotonergic
Mechanism: St John's wort raises serotonin activity; combined with SSRIs, SNRIs or MAOIs it can trigger serotonin syndrome (agitation, tremor, sweating, rapid heartbeat). Reviews of clinical reports document serotonin syndrome and lethargy when it is combined with serotonin-reuptake inhibitors.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Drug Class: antiretrovirals
Mechanism: Potent CYP3A4 and P-glycoprotein induction lowers antiretroviral levels (indinavir exposure fell ~57%), risking loss of viral control and drug resistance.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Drug Class: immunosuppressants
Mechanism: Enzyme and transporter induction reduces ciclosporin and tacrolimus levels; reported to cause subtherapeutic concentrations and transplant rejection.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Drug Class: hormonal-therapies
Mechanism: Increased metabolism of ethinylestradiol and progestins reduces contraceptive exposure, causing breakthrough bleeding, ovulation and unplanned pregnancy. Randomised and controlled trials in women confirmed more breakthrough bleeding, reduced progestin levels and evidence of ovulation when St John's wort was added to the pill.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Drug Class: anticoagulants-antiplatelets
Mechanism: CYP induction increases warfarin clearance and can lower INR, reducing the anticoagulant effect; close monitoring is needed.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Drug Class: cardiac-glycosides
Mechanism: P-glycoprotein induction lowers digoxin levels (AUC fell ~25% over ten days), which may reduce its effect.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Drug Class: statins
Mechanism: CYP3A4 induction lowers levels of simvastatin and atorvastatin, potentially weakening their cholesterol-lowering effect.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Drug Class: cyp3a4-substrates
Mechanism: As a broad CYP3A4 and P-glycoprotein inducer, St John's wort can lower levels of many medicines cleared by this pathway; check each medication individually.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Drug Class: chemotherapy-agents
Mechanism: St John's wort strongly induces CYP3A4 and P-glycoprotein, speeding the breakdown and removal of several cancer medicines. In patients it cut the active form of irinotecan (SN-38) by about 42% and reduced imatinib exposure by roughly a third - enough to weaken treatment and risk drug resistance. Do not take St John's wort during chemotherapy.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Not documented
References
REF-0842, REF-0843, REF-0844, REF-1789, REF-1790, REF-1791, REF-1792, REF-1793, REF-1794, REF-1795, REF-1796, REF-1797, REF-1798, REF-1799
REF-1323, REF-1324, REF-1325, REF-1326, REF-1327, REF-2366, REF-2367, REF-2368, REF-2369, REF-2901, REF-2902, REF-2903, REF-2904, REF-2905, REF-2906, REF-2907, REF-2908, REF-2909, REF-2910, REF-2935, REF-2936, REF-2937, REF-2938, REF-2939, REF-2940, REF-2941, REF-2942, REF-2943, REF-2944
Pairings
St John's wort raises serotonin activity and can cause serotonin syndrome when combined with other serotonin-boosting agents; pairing it with another mood-active, serotonergic herb such as saffron may add to this risk.[30]
Partner Id: crocus-sativus
Type: caution
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
St John's wort is a strong enzyme inducer and increases serotonin activity; combining it with another antidepressant-type herb such as rhodiola may add to serotonergic effects and unpredictably change how each is handled by the body.[30]
Partner Id: rhodiola-rosea
Type: caution
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
St John's wort speeds up the breakdown of many substances and also raises serotonin activity; pairing it with a sedative herb such as valerian may add to drowsiness and can unpredictably change how each is handled by the body.[30, 31]
Partner Id: valeriana-officinalis
Type: caution
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
St John's wort is a strong enzyme inducer and kava is a liver-metabolised sedative; combining them may add to central-nervous-system effects and alter how kava is processed, so combined use warrants caution.[30, 31]
Partner Id: piper-methysticum
Type: caution
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Not documented
Lookalikes Review
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
References & Sources
- Ng, Q.X., Venkatanarayanan, N. and Ho, C.Y.X (2017) 'Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis', Journal of Affective Disorders, 210, pp. 211-221. doi:10.1016/j.jad.2016.12.048 Meta-analysis / review
https://doi.org/10.1016/j.jad.2016.12.048 - Kholghi, G., Arjmandi-Rad, S., Zarrindast, M.R. and Vaseghi, S (2022) 'St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?', Naunyn-Schmiedeberg's Archives of Pharmacology, 395(6), pp. 629-642. doi:10.1007/s00210-022-02229-z Traditional / reference
https://doi.org/10.1007/s00210-022-02229-z - Fugh-Berman, A (2000) 'Herb-drug interactions', Lancet, 355(9198), pp. 134-138. doi:10.1016/S0140-6736(99)06457-0 Traditional / reference
https://doi.org/10.1016/S0140-6736(99)06457-0 - Nobakht, S.Z., Akaberi, M., Mohammadpour, A.H., Tafazoli Moghadam, A. and Emami, S.A (2022) 'Hypericum perforatum: Traditional uses, clinical trials, and drug interactions', Iranian Journal of Basic Medical Sciences, 25(9), pp. 1045-1058. doi:10.22038/IJBMS.2022.65112.14338 Meta-analysis / review
https://doi.org/10.22038/IJBMS.2022.65112.14338 - Jiang, Z., Wang, F., Zhao, Y., Lu, L., Jiang, X., Huang, T., Lin, Y., Guo, L., Weng, Z. and Liu, E (2024) 'Hypericum perforatum L. attenuates depression by regulating Akkermansia muciniphila, tryptophan metabolism and NFkB-NLRP2-Caspase1-IL1beta pathway', Phytomedicine, 132, pp. 155847. doi:10.1016/j.phymed.2024.155847 Preclinical
https://doi.org/10.1016/j.phymed.2024.155847 - Oliveira, A.I., Pinho, C., Sarmento, B. and Dias, A.C.P (2016) 'Neuroprotective Activity of Hypericum perforatum and Its Major Components', Frontiers in Plant Science, 7, pp. 1004. doi:10.3389/fpls.2016.01004 Meta-analysis / review
https://doi.org/10.3389/fpls.2016.01004 - Russo, E., Scicchitano, F., Whalley, B.J., Mazzitello, C., Ciriaco, M., Esposito, S., Patane, M., Upton, R., Pugliese, M., Chimirri, S., Mammi, M., Palleria, C. and De Sarro, G (2013) 'Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions', Phytotherapy Research, 28(5), pp. 643-655. doi:10.1002/ptr.5050 Meta-analysis / review
https://doi.org/10.1002/ptr.5050 - Saddiqe, Z., Naeem, I. and Maimoona, A (2010) 'A review of the antibacterial activity of Hypericum perforatum L', Journal of Ethnopharmacology, 131(3), pp. 511-521. doi:10.1016/j.jep.2010.07.034 Meta-analysis / review
https://doi.org/10.1016/j.jep.2010.07.034 - Mennini, T. and Gobbi, M (2004) 'The antidepressant mechanism of Hypericum perforatum', Life Sciences, 75(9), pp. 1021-1027. doi:10.1016/j.lfs.2004.04.005 Meta-analysis / review
https://doi.org/10.1016/j.lfs.2004.04.005 - Liu, Y., Jiang, Y., Huang, R., Yang, J., Xiao, B. and Dong, J (2013) 'Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety', Climacteric, 17(4), pp. 325-335. doi:10.3109/13697137.2013.861814 Meta-analysis / review
https://doi.org/10.3109/13697137.2013.861814 - Wurglics, M. and Schubert-Zsilavecz, M (2006) 'Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients', Clinical Pharmacokinetics, 45(5), pp. 449-468. doi:10.2165/00003088-200645050-00002 Meta-analysis / review
https://doi.org/10.2165/00003088-200645050-00002 - Kasper, S (2001) 'Hypericum perforatum - a review of clinical studies', Pharmacopsychiatry, 34(Suppl 1), pp. S51-S55. doi:10.1055/s-2001-15467 Meta-analysis / review
https://doi.org/10.1055/s-2001-15467 - Nathan, P (1999) 'The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.)', Molecular Psychiatry, 4(4), pp. 333-338. doi:10.1038/sj.mp.4000557 Meta-analysis / review
https://doi.org/10.1038/sj.mp.4000557 - Verotta, L (2003) 'Hypericum perforatum, a source of neuroactive lead structures', Current Topics in Medicinal Chemistry, 3(2), pp. 187-201. doi:10.2174/1568026033392589 Meta-analysis / review
https://doi.org/10.2174/1568026033392589 - Linde, K. et al (2008) 'St John'. Traditional / reference
https://scholar.google.com/scholar?q=St%20John - Natural Standard (2013) 'Hypericum perforatum (St'. Traditional / reference
https://scholar.google.com/scholar?q=Hypericum%20perforatum%20%28St - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Zhou, S., Chan, E., Pan, S.Q., Huang, M. and Lee, E.J.D (2004) 'Pharmacokinetic interactions of drugs with St John's wort', Journal of Psychopharmacology, 18(2), pp. 262-276. doi:10.1177/0269881104042632 Meta-analysis / review
https://doi.org/10.1177/0269881104042632 - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Borrelli, F. and Izzo, A.A (2009) 'Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations', The AAPS Journal, 11(4), pp. 710-727. doi:10.1208/s12248-009-9146-8 Meta-analysis / review
https://doi.org/10.1208/s12248-009-9146-8 - Nicolussi, S., Drewe, J., Butterweck, V. and Meyer zu Schwabedissen, H.E (2020) 'Clinical relevance of St. John's wort drug interactions revisited', British Journal of Pharmacology, 177(6), pp. 1212-1226. doi:10.1111/bph.14936 Meta-analysis / review
https://doi.org/10.1111/bph.14936 - Piscitelli, S.C., Burstein, A.H., Chaitt, D., Alfaro, R.M. and Falloon, J (2000) 'Indinavir concentrations and St John's wort', Lancet, 355(9203), pp. 547-548. doi:10.1016/S0140-6736(99)05712-8 Clinical study
https://doi.org/10.1016/S0140-6736(99)05712-8 - Barone, G.W., Gurley, B.J., Ketel, B.L., Lightfoot, M.L. and Abul-Ezz, S.R (2000) 'Drug interaction between St. John's wort and cyclosporine', Annals of Pharmacotherapy, 34(9), pp. 1013-1016. doi:10.1345/aph.10088 Clinical study
https://doi.org/10.1345/aph.10088 - Murphy, P.A., Kern, S.E., Stanczyk, F.Z. and Westhoff, C.L (2005) 'Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding', Contraception, 71(6), pp. 402-408. doi:10.1016/j.contraception.2004.11.004 Clinical study
https://doi.org/10.1016/j.contraception.2004.11.004 - Murphy, P.A., Kern, S.E., Stanczyk, F.Z. and Westhoff, C.L (2005) 'Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding', Contraception, 71(6), pp. 402-408. doi:10.1016/j.contraception.2004.11.004 Clinical study
https://doi.org/10.1016/j.contraception.2004.11.004 - Pfrunder, A., Schiesser, M., Gerber, S., Haschke, M., Bitzer, J. and Drewe, J (2003) 'Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial', British Journal of Clinical Pharmacology, 56(6), pp. 683-690. doi:10.1046/j.1365-2125.2003.02005.x Randomized trial
https://doi.org/10.1046/j.1365-2125.2003.02005.x - Johne, A., Brockmoller, J., Bauer, S., Maurer, A., Langheinrich, M. and Roots, I (1999) 'Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)', Clinical Pharmacology and Therapeutics, 66(4), pp. 338-345. doi:10.1053/cp.1999.v66.a101944 Clinical study
https://doi.org/10.1053/cp.1999.v66.a101944 - Mathijssen, R.H.J., Verweij, J., de Bruijn, P., Loos, W.J. and Sparreboom, A (2002) 'Effects of St. John's wort on irinotecan metabolism', Journal of the National Cancer Institute, 94(16), pp. 1247-1249. doi:10.1093/jnci/94.16.1247 Randomized trial
https://doi.org/10.1093/jnci/94.16.1247 - Smith, P., Bullock, J.M., Booker, B.M., Haas, C.E., Berenson, C.S. and Jusko, W.J (2004) 'The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate', Pharmacotherapy, 24(11), pp. 1508-1514. doi:10.1592/phco.24.16.1508.50958 Clinical study
https://doi.org/10.1592/phco.24.16.1508.50958 - Izzo, A.A (2004) 'Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence', International Journal of Clinical Pharmacology and Therapeutics, 42(3), pp. 139-148. doi:10.5414/cpp42139 Meta-analysis / review
https://doi.org/10.5414/cpp42139 - Caus, M.N., Lupoae, M. and Chitescu, C.L (2026) 'Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks', Pharmaceuticals, 19(3), pp. 399. doi:10.3390/ph19030399 Meta-analysis / review
https://doi.org/10.3390/ph19030399
- Ngangom, L., Venugopal, D. and Pandey, N (2024) 'Investigation of Trifolium repens L. from the Indian Himalayan region as a phyto-therapeutic agent', Natural Product Research, 38(24), pp. 4468-4478. doi:10.1080/14786419.2023.2299319 Meta-analysis / review
https://doi.org/10.1080/14786419.2023.2299319 - Ahmad, S. and Zeb, A (2020) 'Phytochemical profile and pharmacological properties of Trifolium repens', Journal of Basic and Clinical Physiology and Pharmacology, 32(3), pp. 20200015. doi:10.1515/jbcpp-2020-0015 Meta-analysis / review
https://doi.org/10.1515/jbcpp-2020-0015 - Sarno, F., Pepe, G., Termolino, P., Carafa, V. and others (2020) 'Trifolium repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway', Cells, 9(2), pp. 379. doi:10.3390/cells9020379 Preclinical
https://doi.org/10.3390/cells9020379 - Ahmad, S. and Zeb, A (2020) 'Nephroprotective property of Trifolium repens leaf extract against paracetamol-induced kidney damage in mice', 3 Biotech, 10(12), pp. 541. doi:10.1007/s13205-020-02539-0 Preclinical
https://doi.org/10.1007/s13205-020-02539-0 - Kolodziejczyk-Czepas, J (2012) 'Trifolium species-derived substances and extracts--biological activity and prospects for medicinal applications', Journal of Ethnopharmacology, 143(1), pp. 14-23. doi:10.1016/j.jep.2012.06.048 Meta-analysis / review
https://doi.org/10.1016/j.jep.2012.06.048 - Chen, Y.H., Chen, P., Wang, Y., Yang, C.H., Wu, X., Wu, C.J., Luo, L., Wang, Q., Niu, C. and Yao, J.Y (2019) 'Structural characterization and anti-inflammatory activity evaluation of chemical constituents in the extract of Trifolium repens L', Journal of Food Biochemistry, 43(9), pp. e12981. doi:10.1111/jfbc.12981 Preclinical
https://doi.org/10.1111/jfbc.12981 - Habibi Zadeh, S.K., Farahpour, M.R. and Kar, H.H (2020) 'The effect of topical administration of an ointment prepared from Trifolium repens hydroethanolic extract on the acceleration of excisional cutaneous wound healing', Wounds, 32(9), pp. 253-261. doi:10.25270/wnds/2020.253261 Preclinical
https://doi.org/10.25270/wnds/2020.253261 - Kicel, A. and Wolbis, M (2012) 'Study on the phenolic constituents of the flowers and leaves of Trifolium repens L', Natural Product Research, 26(21), pp. 2050-2054. doi:10.1080/14786419.2011.637217 Preclinical
https://doi.org/10.1080/14786419.2011.637217 - Ahmad, S. and Zeb, A (2019) 'Effects of phenolic compounds from aqueous extract of Trifolium repens against acetaminophen-induced hepatotoxicity in mice', Journal of Food Biochemistry, 43(9), pp. e12963. doi:10.1111/jfbc.12963 Preclinical
https://doi.org/10.1111/jfbc.12963 - Borczak, B. and Szewczyk, A. and Domagała, D. and Kapusta-Duch, J. and Leszczyńska, T. and Kotuła, M. and Grulova, D (2024) 'Potential Antidiabetic, Antioxidative and Antiproliferative Properties of Functional Wheat Flour Muffins Enriched with White Clover Flowers (Trifolium repens L.)', Int J Mol Sci, 25(18). doi:10.3390/ijms25189909 Preclinical
https://doi.org/10.3390/ijms25189909 - Rawat, P. and Kumar, B. and Misra, A. and Singh, S.P. and Singh, S.P. and Srivastava, S (2025) 'Effect of hydrolysed Trifolium repens L. extract on menopause-induced obesity and depressive symptoms: an in vitro and in vivo approach', Nat Prod Res, pp. 1-8. doi:10.1080/14786419.2025.2560636 Preclinical
https://doi.org/10.1080/14786419.2025.2560636 - Parić, A. and Mesic, A. and Mahmutović-Dizdarević, I. and Jerković-Mujkić, A. and Žujo, B. and Bašić, N. and Pustahija, F (2024) 'Bioactive potential of Trifolium repens L. essential oil', J Environ Sci Health B, 59(9), pp. 584-594. doi:10.1080/03601234.2024.2396730 Preclinical
https://doi.org/10.1080/03601234.2024.2396730 - Renda, G. and Yalçın, F.N. and Nemutlu, E. and Akkol, E.K. and Süntar, I. and Keleş, H. and Ina, H. and Çalış, I. and Ersöz, T (2013) 'Comparative assessment of dermal wound healing potentials of various Trifolium L. extracts and determination of their isoflavone contents as potential active ingredients', J Ethnopharmacol, 148(2), pp. 423-32. doi:10.1016/j.jep.2013.04.031 Preclinical
https://doi.org/10.1016/j.jep.2013.04.031 - Ahmed, I.A.M. and Matthäus, B. and Özcan, M.M. and Juhaimi, F.A. and Ghafoor, K. and Babiker, E.E. and Osman, M.A. and Alqah, H.A.S (2020) 'Determination of Bioactive Lipid and Antioxidant Activity of Onobrychis, Pimpinella, Trifolium, and Phleum spp. Seed and Oils', J Oleo Sci, 69(11), pp. 1367-1371. doi:10.5650/jos.ess20153 Preclinical
https://doi.org/10.5650/jos.ess20153 - Harlow, B.E. and Flythe, M.D. and Goodman, J.P. and Ji, H. and Aiken, G.E (2022) 'Isoflavone Containing Legumes Mitigate Ergot Alkaloid-Induced Vasoconstriction in Goats (Capra hircus)', Animals (Basel), 12(6). doi:10.3390/ani12060750 Preclinical
https://doi.org/10.3390/ani12060750 - Shang, H. and Li, R. and Wu, H. and Sun, Z (2019) 'Polysaccharides from Trifolium repens L. extracted by different methods and extraction condition optimization', Sci Rep, 9(1), pp. 6353. doi:10.1038/s41598-019-42877-5 Preclinical
https://doi.org/10.1038/s41598-019-42877-5 - Prati, S. and Baravelli, V. and Fabbri, D. and Schwarzinger, C. and Brandolini, V. and Maietti, A. and Tedeschi, P. and Benvenuti, S. and Macchia, M. and Marotti, I. and Bonetti, A. and Catizone, P. and Dinelli, G (2007) 'Composition and content of seed flavonoids in forage and grain legume crops', J Sep Sci, 30(4), pp. 491-501. doi:10.1002/jssc.200600383 Preclinical
https://doi.org/10.1002/jssc.200600383 - Woolsey, I.D. and Zeller, W.E. and Blomstrand, B.M. and Øines, Ø. and Enemark, H.L (2022) 'Effects of selected condensed tannins on Cryptosporidium parvum growth and proliferation in HCT-8 cell cultures', Exp Parasitol, 241, pp. 108353. doi:10.1016/j.exppara.2022.108353 Preclinical
https://doi.org/10.1016/j.exppara.2022.108353 - Hou, K. and Xue, Q. and Shi, L. and Liu, S. and Zhong, X. and Liu, Y. and Wang, C (2026) 'Identification of Trifolium repens as a New Source of Glycyrrhetinic Acid: Pathway Elucidation and Heterologous Reconstruction in Yeast', J Agric Food Chem, 74(19), pp. 15182-15194. doi:10.1021/acs.jafc.6c02001 Preclinical
https://doi.org/10.1021/acs.jafc.6c02001 - Tundis, R. and Marrelli, M. and Conforti, F. and Tenuta, M.C. and Bonesi, M. and Menichini, F. and Loizzo, M.R (2015) 'Trifolium pratense and T. repens (Leguminosae): Edible Flower Extracts as Functional Ingredients', Foods, 4(3), pp. 338-348. doi:10.3390/foods4030338 Preclinical
https://doi.org/10.3390/foods4030338 - Başar, Y. and Yıldız, İ. and HOSAFLIOĞLU, İ. and Azeroual, A. and Erenler, R (2026) 'The Phytochemical Content and DPPH Activity of Trifolium repens L. Methanol Extract, and In Silico Studies', Adıyaman üniversitesi fen bilimleri dergisi, 16(1), pp. 61-76. doi:10.37094/adyujsci.1813336 Preclinical
https://doi.org/10.37094/adyujsci.1813336 - Ayoubi, S.A. and Abdelwahab, I. and Ela, M.A. and Lakany, A.E. and Raafat, K (2026) 'Advanced Hybrid-Green Ultrasound–Infrared–Microwave Trifolium repens Essential oil Isolation with Multi-Target Ethnomedicine Bioactivity against Neuropathy, Inflammation and Multidrug-Resistant Infection', Journal of Food and Drug Analysis, 34(2). doi:10.38212/2224-6614.3595 Preclinical
https://doi.org/10.38212/2224-6614.3595 - Ahmad, S. and Zeb, A. and Ayaz, M. and Murkovic, M (2019) 'Characterization of phenolic compounds using UPLC–HRMS and HPLC–DAD and anti-cholinesterase and anti-oxidant activities of Trifolium repens L. leaves', European Food Research and Technology, 246(3), pp. 485-496. doi:10.1007/s00217-019-03416-8 Preclinical
https://doi.org/10.1007/s00217-019-03416-8 - Petrović, M. and Stanković, M. and Anđelković, B. and Babić, S. and Zornić, V. and Vasiljević, S. and Stevanović, Z.D (2016) 'Quality Parameters and Antioxidant Activity of Three Clover Species in Relation to the Livestock Diet', Notulae Botanicae Horti Agrobotanici Cluj-Napoca, 44(1), pp. 201-208. doi:10.15835/nbha44110144 Preclinical
https://doi.org/10.15835/nbha44110144 - Jakubczyk, K. and Łukomska, A. and Gutowska, I. and Kochman, J. and Janił, J. and Janda, K (2021) 'Edible Flowers Extracts as a Source of Bioactive Compounds with Antioxidant Properties—In Vitro Studies', Applied Sciences, 11(5), pp. 2120-2120. doi:10.3390/app11052120 Preclinical
https://doi.org/10.3390/app11052120 - Ngangom, L. and Venugopal, D. and Pandey, N. and Kumar, N (2022) 'In-silico screening and identification of potential bioactive compounds of Trifolium repens against pathogenic bacterial target proteins', Materials Today Proceedings, 73, pp. 142-150. doi:10.1016/j.matpr.2022.09.501 Preclinical
https://doi.org/10.1016/j.matpr.2022.09.501 - Amer, B. and Juul, L. and Møller, A.H. and Møller, H.S. and Dalsgaard, T.K (2020) 'Improved solubility of proteins from white and red clover – inhibition of redox enzymes', International Journal of Food Science & Technology, 56(1), pp. 302-311. doi:10.1111/ijfs.14632 Preclinical
https://doi.org/10.1111/ijfs.14632 - Pap, N. and Granato, D. and Järvenpää, E. and Tienaho, J. and Marnila, P. and Hellström, J. and Pihlava, J. and Franco, M. and Stefański, T. and Rinne, M (2024) 'Biorefining of legume and grass biomasses: Technological properties and bioactivities of the green juice', Future Foods, 9, pp. 100331-100331. doi:10.1016/j.fufo.2024.100331 Preclinical
https://doi.org/10.1016/j.fufo.2024.100331 - Ahn, C. and Lee, J. and Park, M.J. and Kim, J. and Yang, J. and Yoo, Y. and Jeung, E (2020) 'Cytostatic effects of plant essential oils on human skin and lung cells', Experimental and Therapeutic Medicine, 19(3), pp. 2008-2018. doi:10.3892/etm.2020.8460 Preclinical
https://doi.org/10.3892/etm.2020.8460 - Bhattacharya, S. et al (2013) 'Review of the botanical, phytochemical, pharmacological and toxicological properties of white clover (Trifolium repens L.)', 7(7), pp. 583--588. Traditional / reference
https://scholar.google.com/scholar?q=Review%20of%20the%20botanical%2C%20phytochemical%2C%20pharmacological%20and%20toxicological%20properties%20of%20white%20clover%20%28Trifolium%20repens%20L.%29 - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Klaiber, I. et al (2002) 'Health benefits of isoflavones from clover species', 16(1), pp. 1--8. Traditional / reference
https://scholar.google.com/scholar?q=Health%20benefits%20of%20isoflavones%20from%20clover%20species - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.